Imagen de Portada

Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Jeremy Cheng, Mohammadmehdi Adhami, Tho Pham, David P. Nadebaum, Ashley Baring, Eldho Paul, Martin Cherk, Jeremy Grummet
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	BJUI Compass
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

PSMA PET/CT findings in high‐risk biochemical recurrence after local treatment of prostate cancer
por: Nicole Handa, et al.
Publicado: (2025)

A population‐based analyses of the evolving management of cN1M0 prostate cancer in the PSMA‐PET era
por: Jennifer Ward, et al.
Publicado: (2025)

Oncological outcomes post focal low‐dose‐rate brachytherapy in low‐intermediate risk prostate cancer
por: Mohammadmehdi Adhami, et al.
Publicado: (2026)

Cost‐effectiveness analysis of a biopsy‐free diagnostic strategy for prostate cancer using mpMRI and PSMA‐PET/CT
por: Joshua Yi Min Tung, et al.
Publicado: (2026)

Anatomical distribution of disease in pN1 prostate cancer with BCR post‐RP: A PSMA‐PET/CT‐based analysis
por: Lotte G. Zuur, et al.
Publicado: (2025)

Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
por: Abel Tesfai, et al.
Publicado: (2024)

The accuracy of ultrasensitive PSA in predicting disease progression after radical prostatectomy
por: Heikki Seikkula, et al.
Publicado: (2024)

Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
por: Maxwell Louis Sandberg, et al.
Publicado: (2026)

Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
por: Eric Margolis, et al.
Publicado: (2025)

Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
por: Samantha Shekar, et al.
Publicado: (2025)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
por: Esther H. J. Hamoen, et al.
Publicado: (2025)

The carbon footprint of transperineal prostate biopsy
por: Daniel A. Carson, et al.
Publicado: (2025)

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
por: Eric V. Li, et al.
Publicado: (2024)

Targeted Prostate Health Checks, a novel system to identify men with prostate cancer—A pilot study
por: Stephen Langley, et al.
Publicado: (2024)

Emerging tools for the early detection of prostate cancer
por: Muhammad Haider, et al.
Publicado: (2025)

Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
por: Sophia M. Abusamra, et al.
Publicado: (2025)

Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
por: Ansh Bhatia, et al.
Publicado: (2024)

Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer
por: Austin Drysch, et al.
Publicado: (2025)

Bibliometric analysis of focal therapy in prostate cancer research
por: Mohammed Shahait, et al.
Publicado: (2024)

Day‐case artificial urinary sphincter for post‐prostatectomy incontinence: A comparative pilot study
por: Konstantinos Kapriniotis, et al.
Publicado: (2024)

‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
por: Ryan Sutherland, et al.
Publicado: (2024)

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
por: Ailene E. Corona, et al.
Publicado: (2026)

The impact of vaporization on adenoma weight in benign prostatic hyperplasia surgery
por: André B. Silva, et al.
Publicado: (2026)

Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
por: Mathew Thakur, et al.
Publicado: (2024)

National survey of urologists' views on prostate cancer screening in the United Kingdom
por: Nikhil Mayor, et al.
Publicado: (2026)

Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
por: Nadia Rokan, et al.
Publicado: (2025)

Multidisciplinary meetings for lower urinary tract symptoms and benign prostate hyperplasia
por: Emilien Seizilles de Mazancourt, et al.
Publicado: (2025)

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
por: Ruth Pidsley, et al.
Publicado: (2024)

WATER versus WATER II 5‐year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80‐cm3 and 80–150‐cm3 prostates
por: Mohamad Baker Berjaoui, et al.
Publicado: (2024)

The significant costs of prostate cancer management—An analysis from a Caribbean hospital
por: Geneva Pantoja, et al.
Publicado: (2025)

Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
por: Sofia Mesquita, et al.
Publicado: (2025)

Evaluating the utility of the HAS‐BLED bleeding‐estimator tool for transurethral resection of prostate
por: Lu Yu Kuo, et al.
Publicado: (2025)

Risk factors of negative prostate biopsies: A CHAID decision tree analysis
por: Pierre Allainguillaume, et al.
Publicado: (2026)

Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
por: Jonathon Dawson, et al.
Publicado: (2024)

A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients
por: Marcus Sondermann, et al.
Publicado: (2025)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
por: Arjun Pon Avudaiappan, et al.
Publicado: (2024)

Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
por: Muhammad Haider, et al.
Publicado: (2025)

AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
por: Muhammad Imran, et al.
Publicado: (2026)

Potential gains from radical treatment of men with prostate cancer according to life expectancy
por: Sandra Irenaeus, et al.
Publicado: (2025)

Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm
por: Alan Priester, et al.
Publicado: (2024)